BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31447850)

  • 1. Have Cells Harboring the HIV Reservoir Been Immunoedited?
    Huang SH; McCann CD; Mota TM; Wang C; Lipkin SM; Jones RB
    Front Immunol; 2019; 10():1842. PubMed ID: 31447850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
    Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
    EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.
    Mylvaganam G; Yanez AG; Maus M; Walker BD
    Front Immunol; 2019; 10():2109. PubMed ID: 31552045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.
    Huang SH; Ren Y; Thomas AS; Chan D; Mueller S; Ward AR; Patel S; Bollard CM; Cruz CR; Karandish S; Truong R; Macedo AB; Bosque A; Kovacs C; Benko E; Piechocka-Trocha A; Wong H; Jeng E; Nixon DF; Ho YC; Siliciano RF; Walker BD; Jones RB
    J Clin Invest; 2018 Feb; 128(2):876-889. PubMed ID: 29355843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 as a Model for Virus and Host Coordinated Immunoediting.
    Mota TM; Jones RB
    Front Immunol; 2019; 10():2259. PubMed ID: 31616431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
    Deng K; Pertea M; Rongvaux A; Wang L; Durand CM; Ghiaur G; Lai J; McHugh HL; Hao H; Zhang H; Margolick JB; Gurer C; Murphy AJ; Valenzuela DM; Yancopoulos GD; Deeks SG; Strowig T; Kumar P; Siliciano JD; Salzberg SL; Flavell RA; Shan L; Siliciano RF
    Nature; 2015 Jan; 517(7534):381-5. PubMed ID: 25561180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation.
    Li P; Kaiser P; Lampiris HW; Kim P; Yukl SA; Havlir DV; Greene WC; Wong JK
    Nat Med; 2016 Jul; 22(7):807-11. PubMed ID: 27294875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The forces driving clonal expansion of the HIV-1 latent reservoir.
    Liu R; Simonetti FR; Ho YC
    Virol J; 2020 Jan; 17(1):4. PubMed ID: 31910871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.
    Jones RB; Mueller S; O'Connor R; Rimpel K; Sloan DD; Karel D; Wong HC; Jeng EK; Thomas AS; Whitney JB; Lim SY; Kovacs C; Benko E; Karandish S; Huang SH; Buzon MJ; Lichterfeld M; Irrinki A; Murry JP; Tsai A; Yu H; Geleziunas R; Trocha A; Ostrowski MA; Irvine DJ; Walker BD
    PLoS Pathog; 2016 Apr; 12(4):e1005545. PubMed ID: 27082643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
    J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.
    Cunyat F; Rainho JN; West B; Swainson L; McCune JM; Stevenson M
    J Virol; 2016 Jul; 90(14):6255-6262. PubMed ID: 27122585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.
    Pinzone MR; Graf E; Lynch L; McLaughlin B; Hecht FM; Connors M; Migueles SA; Hwang WT; Nunnari G; O'Doherty U
    J Virol; 2016 Dec; 90(23):10436-10445. PubMed ID: 27630237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir
    Ollerton MT; Berger EA; Connick E; Burton GF
    J Virol; 2020 May; 94(10):. PubMed ID: 32161179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells.
    Sung JA; Sholtis K; Kirchherr J; Kuruc JD; Gay CL; Nordstrom JL; Bollard CM; Archin NM; Margolis DM
    EBioMedicine; 2017 Sep; 23():52-58. PubMed ID: 28803740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.
    Thomas AS; Jones KL; Gandhi RT; McMahon DK; Cyktor JC; Chan D; Huang SH; Truong R; Bosque A; Macedo AB; Kovacs C; Benko E; Eron JJ; Bosch RJ; Lalama CM; Simmens S; Walker BD; Mellors JW; Jones RB
    PLoS Pathog; 2017 Sep; 13(9):e1006629. PubMed ID: 28931091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of integration and clonal expansion in HIV infection: live long and prosper.
    Anderson EM; Maldarelli F
    Retrovirology; 2018 Oct; 15(1):71. PubMed ID: 30352600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.